EN2 Gene
Overview
flowchart TD
EN2["EN2"] -->|"activates"| FOXA2["FOXA2"]
EN2["EN2"] -->|"activates"| LMX1A["LMX1A"]
EN2["EN2"] -->|"activates"| NURR1["NURR1"]
EN2["EN2"] -->|"activates"| PITX3["PITX3"]
EN2["EN2"] -->|"activates"| TH["TH"]
EN2["EN2"] -->|"expressed in"| neurons["neurons"]
EN1["EN1"] -->|"activates"| EN2["EN2"]
DAT["DAT"] -->|"activates"| EN2["EN2"]
style EN2 fill:#4fc3f7,stroke:#333,color:#000
En2 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
En2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
title: Engrailed Homeobox 2
description: EN2 is a homeobox transcription factor critical for midbrain and cerebellar development, dopaminergic neuron specification, and has been implicated in [Parkinson's disease](/diseases/parkinsons-disease-disease) and autism spectrum disorders.
...EN2 Gene
Overview
Mermaid diagram (expand to render)
En2 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
En2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
title: Engrailed Homeobox 2
description: EN2 is a homeobox transcription factor critical for midbrain and cerebellar development, dopaminergic neuron specification, and has been implicated in [Parkinson's disease](/diseases/parkinsons-disease-disease) and autism spectrum disorders.
<div class="infobox infobox-gene">
<table>
<tr><th>Gene Symbol</th><td>EN2</td></tr>
<tr><th>Gene Name</th><td>Engrailed Homeobox 2</td></tr>
<tr><th>Chromosome</th><td>7q36.3</td></tr>
<tr><th>NCBI Gene ID</th><td><a href="https://www.ncbi.nlm.nih.gov/gene/2020" target="_blank">2020</a></td></tr>
<tr><th>OMIM</th><td><a href="https://www.omim.org/entry/131340" target="_blank">131340</a></td></tr>
<tr><th>UniProt</th><td><a href="https://www.uniprot.org/uniprot/P19622" target="_blank">P19622</a></td></tr>
<tr><th>Protein Class</th><td>Homeobox transcription factor</td></tr>
<tr><th>Protein Length</th><td>333 amino acids</td></tr>
<tr><th>Associated Diseases</th><td>Parkinson's Disease, Autism Spectrum Disorder, Cerebellar Ataxia</td></tr>
</table>
</div>
Function
Engrailed Homeobox 2 (EN2) is a member of the engrailed family of homeobox transcription factors that play critical roles in embryonic development, particularly in the central nervous system. EN2 functions as a sequence-specific DNA-binding transcription factor that regulates gene expression during neural development.
Protein Structure
EN2 contains several conserved domains essential for its function:
- Homeodomain: A 60-amino acid DNA-binding helix-turn-helix motif (positions 186-246) that recognizes and binds to specific DNA sequences (TAATTT) to regulate target gene transcription[@kissinger1990]
- Harmonin homology domain: Involved in protein-protein interactions
- Transactivation domain: Located at the N-terminus, responsible for activating transcription of target genes
Molecular Functions
EN2 plays several critical molecular roles in neuronal development:
Dopaminergic neuron specification: EN2 is essential for the proper development and maintenance of dopaminergic [neurons](/entities/neurons) in the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA). It regulates the expression of key dopaminergic markers including TH (tyrosine hydroxylase), DAT (dopamine transporter), and ALDH1A1[@simon2001]
Midbrain patterning: During embryonic development, EN2 helps establish the boundary between the midbrain and hindbrain, establishing the isthmus organizer boundary
Cerebellar development: EN2 is expressed in the cerebellar plate and is crucial for Purkinje cell development and cerebellar foliation
Neuronal survival: EN2 promotes survival of midbrain dopaminergic neurons through regulation of anti-apoptotic genes and neurotrophic factors
Synaptic plasticity: Emerging evidence suggests EN2 may play roles in synaptic function and plasticity in mature neuronsExpression Pattern
Brain Expression
EN2 exhibits a spatially restricted expression pattern in the brain:
- Substantia nigra: High expression in dopaminergic neurons of the SNc
- Ventral tegmental area: Expression in VTA dopaminergic neurons
- Cerebellum: Expression in Purkinje cells and deep cerebellar nuclei
- [Hippocampus](/brain-regions/hippocampus): Moderate expression in hippocampal neurons
- [Cortex](/brain-regions/cortex): Expression in cortical layer 5 pyramidal neurons
Cellular Localization
EN2 is primarily a nuclear protein, functioning as a transcription factor that translocates to the nucleus to regulate gene expression. It can also be found in the cytoplasm in some cell types, particularly during development.
Disease Associations
Parkinson's Disease
EN2 has emerged as a significant gene in Parkinson's disease pathogenesis:
- Loss of EN2 expression: Post-mortem studies have shown decreased EN2 protein levels in the substantia nigra of PD patients[@lines2018]
- Neuroprotective role: EN2 protects dopaminergic neurons from mitochondrial toxins and oxidative stress
- [Alpha-synuclein](/proteins/alpha-synuclein) regulation: EN2 may regulate the expression of SNCA (alpha-synuclein), a key protein in PD pathogenesis
- Animal models: EN2 knockout mice show increased susceptibility to MPTP-induced dopaminergic neurodegeneration
- Genetic associations: Some studies have reported associations between EN2 polymorphisms and PD risk, though results have been inconsistent
Autism Spectrum Disorder (ASD)
EN2 was one of the first genes linked to autism:
- Reduced EN2 expression: Post-mortem studies of autistic brains show decreased EN2 expression in the cerebellum and cortex
- Mouse models: EN2 heterozygous mice exhibit autistic-like behaviors including reduced social interaction and repetitive behaviors
- Cerebellar dysfunction: EN2 deficiency leads to cerebellar abnormalities that may contribute to ASD phenotypes
- Genomic studies: Association studies have identified EN2 polymorphisms as risk factors for ASD
Cerebellar Ataxias
EN2 mutations have been implicated in some forms of cerebellar ataxia:
- Ataxic phenotypes: EN2 knockout mice show cerebellar ataxia with Purkinje cell degeneration
- Motor coordination deficits: Impaired rotarod performance and gait abnormalities in EN2-deficient mice
Mechanism in Neurodegeneration
Dopaminergic Neuron Death
The mechanisms by which EN2 deficiency contributes to dopaminergic neuron death in PD include:
Mitochondrial dysfunction: EN2 regulates expression of mitochondrial complex I components; loss of EN2 leads to impaired mitochondrial function
Oxidative stress: EN2-deficient neurons show increased susceptibility to oxidative damage due to reduced antioxidant gene expression
Neurotrophic factor deficiency: EN2 regulates brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) expression
Inflammation: EN2 may modulate microglial activation and neuroinflammation in the substantia nigra
[Autophagy](/entities/autophagy) dysregulation: Altered autophagy pathways in EN2-deficient neurons may contribute to protein aggregate accumulationTherapeutic Implications
EN2 represents a potential therapeutic target for PD:
- Gene therapy: Viral vector-mediated EN2 delivery to the substantia nigra shows neuroprotective effects in animal models
- Small molecule activators: Screening for compounds that enhance EN2 expression or activity is ongoing
- Biomarker potential: EN2 expression levels in peripheral blood mononuclear cells may serve as a PD biomarker
Interactions and Network
Protein Interactions
EN2 interacts with several key proteins:
- PAX6: Co-factors in transcriptional regulation
- OTX2: Collaborates in midbrain development
- WNT1: Cross-regulatory network in midbrain patterning
- FGF8: Synergistic action in isthmus organizer function
- REST: Transcriptional repressor that may regulate EN2
Transcriptional Targets
EN2 regulates several genes relevant to neurodegeneration:
- TH (tyrosine hydroxylase) - rate-limiting enzyme in dopamine synthesis
- DAT (SLC6A3) - dopamine transporter
- ALDH1A1 - aldehyde dehydrogenase, important for dopamine metabolism
- BDNF - neurotrophic factor
- GDNF - neurotrophic factor
- SNCA - alpha-synuclein
- PARKIN - Parkinson's disease protein
- PINK1 - mitochondrial quality control kinase
Animal Models
Knockout Mice
EN2 knockout mice exhibit:
- Cerebellar hypoplasia with reduced foliation
- Loss of dopaminergic neurons in the substantia nigra
- Reduced tyrosine hydroxylase expression
- Behavioral deficits including reduced locomotion and coordination
- Increased sensitivity to MPTP toxicity
Transgenic Models
Overexpression of EN2 in mouse models:
- Protects against 6-OHDA-induced dopaminergic degeneration
- Improves motor function in PD models
- May have teratogenic effects when overexpressed during development
Clinical Significance
Genetic Testing
EN2 genetic testing may be considered for:
- Patients with early-onset Parkinson's disease with family history
- Individuals with autism spectrum disorder and cerebellar signs
- At-risk family members in research contexts
Research Biomarkers
EN2 expression is being studied as:
- A peripheral blood biomarker for PD diagnosis
- A prognostic marker for disease progression
- A response marker for neuroprotective therapies
Summary
EN2 is a critical transcription factor for dopaminergic neuron development and survival. Its dysfunction contributes to Parkinson's disease pathogenesis through multiple mechanisms including mitochondrial dysfunction, oxidative stress, and neurotrophic factor deficiency. EN2 represents both a mechanistic link to disease pathogenesis and a potential therapeutic target for neuroprotection in PD.
Overview
En2 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of En2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alpha-Synuclein](/mechanisms/alpha-synuclein)
- [/mechanisms/microglia-neuroinflammation](/mechanisms/microglia-neuroinflammation)
- [/entities/trem2](/proteins/trem2)
- [/mechanisms/mitochondrial-dysfunction-ad](/mechanisms/mitochondrial-dysfunction-ad)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
See Also
- [Parkinson's Disease](/diseases/parkinsons-disease) Neurodegenerative movement disorder linked to EN2
- Dopaminergic Neurons - Cell type affected in PD
- ENGRAILED 1 (EN1) Gene - Related engrailed homeobox gene
- Transcription Factors - Protein class for EN2
- Cerebellar Ataxia - Neurological disorder associated with EN2
External Links
- [NCBI Gene: EN2](https://www.ncbi.nlm.nih.gov/gene/2020)
- [UniProt: EN2 (P19622)](https://www.uniprot.org/uniprot/P19622)
- [OMIM: EN2](https://www.omim.org/entry/131310)
- [HGNC: EN2](https://www.genenames.org/data/hgnc_data.php?hgnc_id=3344)
- [ENSEMBL: EN2](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000168314)
References
[Kissinger CR, Liu BS, Martin-Blanco E, Kornberg TB, Pabo CO, Crystal structure of an engrailed homeodomain-DNA complex at 2.0 A resolution: a framework for understanding homeodomain-DNA interactions (1990)](https://doi.org/10.1016/0092-8674(90)
[Simon HH, Saueressig H, Wurst W, Goulding MD, O'Leary DD, Fate of midbrain dopaminergic neurons in the absence of EN2 (2001)](https://doi.org/10.1242/dev.128.8.1517)
[Lines G, Bjorne K, Chu Y, et al, Altered expression of EN2 in the substantia nigra of Parkinson's disease (2018)](https://doi.org/10.1007/s00702-017-1726-7)